Sponsors
Piper Jaffray
Piper Jaffray Ltd. is a leading investment bank servicing the UK small/mid-cap health care sector. The firm is the retained financial adviser and/or broker to 54% of the companies comprising the techMARK mediscience index. Piper Jaffray Ltd. makes markets in over 30 LSE full and AIM-listed health care stocks, has research coverage of 40 European health care stocks and the ability to distribute this research product both in Europe and in the United States. The firm has extensive experience in the health care and technology sectors.
Having been involved in 12 of the top 30 European biotech equity financing transactions (six as bookrunner) since the beginning of 2006, Piper Jaffray Ltd. has raised more money for European biotech companies than any other investment bank. Over the same period, the firm was responsible for over 70% of all secondary equity financing raised in the UK biotech sector. Piper Jaffray Ltd. has advised on eight M&A transactions since the beginning of 2006, six of which were cross-border.
Piper Jaffray Ltd. is a subsidiary of Piper Jaffray Companies, a leading, international middle market investment bank and NYSE-listed institutional securities firm with a market cap of c. US$725 million. It offers investment banking, equity research and equity sales and trading within Europe to middle market corporations, private equity groups and institutional investors. Piper Jaffray Ltd. is authorised and regulated by the Financial Services Authority and is a member of the London Stock Exchange.
Piper Jaffray is proud to sponsor the London Stock Exchange Mediscience awards dinner.
For further information: www.piperjaffray.co.uk
London Stock Exchange
Once again the London Stock Exchange is delighted to be sponsoring the london stock exchange mediscience awards dinner, celebrating the achievements of outstanding healthcare companies over the past year.
techMARK mediscience was the world’s first global market segment for healthcare companies. Its purpose then as now, is to encourage increased investor attention on those innovative science and technology companies committed to significant research and development and striving to become world leaders in their field.
For further information: www.londonstockexchange.com/techmark
BioIndustry Association
The BioIndustry Association (BIA) actively represents the interests of its 300 members, from the UK bioscience community, to a broad range of stakeholders. It promotes the human health benefits of the UK's innovative research and development base, both nationally and internationally. Members benefit from preferential, discounted attendance at exclusive BIA events designed to stimulate, inform and spread industry best practice.
Headquartered in London, the BIA also has an office in Edinburgh to serve the interests of our Scottish members.
For further information: www.bioindustry.org
Reed Smith Richards Butler
Reed Smith Richards Butler is an international law firm with an outstanding life sciences practice both in Europe and in the US. The team includes several individuals who have been recognised as leaders in their fields. Many of our lawyers have experience working in life sciences companies and combine legal excellence with scientific expertise. Our lawyers develop innovative, cost effective solutions specifically tailored to our clients in this rapidly evolving sector.
We provide advice on the full range of corporate, commercial, intellectual property and regulatory matters for life sciences companies. Our clients include the largest pharmaceutical corporations, mid-market and early-stage biotechnology companies, medical device and diagnostics firms and health care providers.
To find out more, contact John Wilkinson on:
+44 (0) 20 7556 6825 or jwilkinson@reedsmith.com
For further information: www.reedsmith.com
McGrigors
McGrigors is a full service commercial law firm with over 350 fee earners operating from five offices throughout the UK. McGrigors’ Capital Markets practice handles domestic and international IPOs and fundraisings and is one of the most active in the UK. In 2006 McGrigors advised on 15 AIM transactions, raising over £365 million and on over 80 pre-IPO investments for companies in a range of sectors. We have a particular expertise in life sciences and have recently acted in the AIM flotations of EpiStem Holdings plc, Neuropharm Group plc and the dual listing of Stem Cell Sciences plc on ASX. McGrigors is delighted to be sponsoring the Best Newcomer Award for the third year running.
For further information: www.mcgrigors.com
Buchanan Communications
Buchanan Communications is a leading City financial public relations agency with a particular specialism in the life science arena. The agency has built up an exciting and diverse client portfolio ranging from profitable pharmaceutical companies through to platform and drug discovery companies. Currently Buchanan advises more than 40 life science clients. The Buchanan life science team is headed up by Tim Anderson, a founder of Buchanan Communications, with each of the key partners and directors in the team having over ten years’ direct experience of the life science sector.
For further information: www.buchanan.uk.com
Evolution Securities
Evolution Securities is the investment banking business of Evolution Group plc, providing equity research, institutional sales and trading, corporate broking, investor relations and corporate finance advice in the quoted small, mid and large-cap sectors.
We act as Financial Adviser and/or Stockbroker to more than 90 publicly quoted companies (both AIM and full list), make markets in over 1,200 companies and provide equity research coverage on over 250 companies. Our specialist sectors include Mining, Oil & Gas, Utilities & Renewables, Support Services, Consumer, Consumer Cyclical, Healthcare, Financials, Technology & Telecoms and Industrials.
In 2006 we raised over £720 million for our corporate clients, with a total deal value of over £1.2 billion.
We take a personal interest in our clients' businesses allowing us to build a comprehensive knowledge of their strategy thereby enabling us to provide objective and timely advice.
Evolution Securities is proud to sponsor the London Stock Exchange Mediscience awards dinner.
For further information: www.uk.evosecurities.com
Menu Sponsor
The Design Portfolio Marketing Services
The Design Portfolio Marketing Services is one of the UK’s leading Corporate Reporting consultancies. It works with over 150 London Stock Exchange quoted company clients, designing and producing award winning and cost effective annual reports from our offices in London, Cambridge, Leeds, Gatwick and Miami.
We work closely with a number of clients in the mediscience sector, where good communication and value for money are more important than ever.
Congratulations to all the nominees – we wish you all the best of luck tonight and continued success in the future.
For further information: www.design-portfolio.co.uk